Infiltrating mast cells enhance benign prostatic hyperplasia through IL-6/STAT3/Cyclin D1 signals

Early evidences have showed that mast cells could infiltrate into benign prostatic hyperplasia (BPH) tissues, but the exact role of mast cells in BPH development remains unclear. In this study, we identified more mast cells existing in human BPH tissues compared with that in the normal prostate. In the in vitro co-culture system, BPH-1 prostate cells promoted activation and migration of mast cells, and mast cells conversely stimulated BPH-1 cells proliferation significantly. Molecular analysis demonstrated that mast cell-derived interleukin 6 (IL-6) could activate STAT3/Cyclin D1 signals in BPH-1 cells. Blocking IL-6 or STAT3 partially reverse the capacity of mast cells to enhance BPH-1 cell proliferation. Our findings suggest that infiltrating mast cells in BPH tissues could promote BPH development via IL-6/STAT3/Cyclin D1 signals. Therefore, targeting infiltrating mast cells may improve the therapeutic effect of BPH.

[1]  Yue Xu,et al.  IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells , 2017, Oncotarget.

[2]  H. Xie,et al.  Aberrant Transforming Growth Factor‐β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia , 2016, Stem cells translational medicine.

[3]  M. Carini,et al.  Benign Prostatic Hyperplasia, Metabolic Syndrome and Non‐Alcoholic Fatty Liver Disease: Is Metaflammation the Link? , 2016, The Prostate.

[4]  C. Roehrborn,et al.  Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention. , 2016, The Journal of urology.

[5]  J. Ryu,et al.  Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell , 2016, The Prostate.

[6]  X. Chen,et al.  Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR , 2016, Oncotarget.

[7]  X. Zu,et al.  LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia , 2016, Scientific Reports.

[8]  Melissa M. Norström,et al.  Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes , 2016, Oncotarget.

[9]  S. Yeh,et al.  Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals , 2015, Oncotarget.

[10]  R. Sagi-Eisenberg,et al.  Down-regulation of the A3 adenosine receptor in human mast cells upregulates mediators of angiogenesis and remodeling. , 2015, Molecular immunology.

[11]  Qiang Yu,et al.  Inhibition of STAT3/cyclinD1 pathway promotes chemotherapeutic sensitivity of colorectal caner. , 2015, Biochemical and biophysical research communications.

[12]  J. Marshall,et al.  Mast cells as targets for immunotherapy of solid tumors. , 2015, Molecular immunology.

[13]  Hua Yu,et al.  Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.

[14]  M. Raica,et al.  Mast cell phenotype in benign and malignant tumors of the prostate. , 2014, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[15]  A. Tewari,et al.  Inflammation and prostate cancer: the role of interleukin 6 (IL‐6) , 2014, BJU international.

[16]  S. Xie,et al.  Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium. , 2014, International journal of clinical and experimental pathology.

[17]  R. Hwang,et al.  Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. , 2013, Cancer research.

[18]  H. Jung,et al.  Is Increased Prostatic Urethral Angle Related to Lower Urinary Tract Symptoms in Males with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms? , 2012, Korean journal of urology.

[19]  Xiaohai Wang,et al.  Increased Infiltrated Macrophages in Benign Prostatic Hyperplasia (BPH) , 2012, The Journal of Biological Chemistry.

[20]  I. Alafuzoff,et al.  Mast Cell Accumulation in Glioblastoma with a Potential Role for Stem Cell Factor and Chemokine CXCL12 , 2011, PloS one.

[21]  Robert L. Sutherland,et al.  Cyclin D as a therapeutic target in cancer , 2011, Nature Reviews Cancer.

[22]  A. Kozubík,et al.  TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells. , 2010, Cellular signalling.

[23]  G. Ling,et al.  Mast Cell Infiltration Is Involved in Renal Interstitial Fibrosis in a Rat Model of Protein-Overload Nephropathy , 2010, Kidney and Blood Pressure Research.

[24]  M. Truss,et al.  Quantitative Study of Mast Cells in Experimentally Induced Benign Prostatic Hyperplasia , 2010, Urologia Internationalis.

[25]  S. Terry,et al.  Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis , 2009, The Prostate.

[26]  G. Kramer,et al.  Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? , 2007, European urology.

[27]  E. Bergstralh,et al.  Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia , 2006, The Prostate.

[28]  A. Aydın,et al.  Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. , 2006, Clinical biochemistry.

[29]  Lieve Moons,et al.  CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. , 2005, Cancer research.

[30]  L. Hültner,et al.  Mast cells and inflammation. , 2002, Archivum immunologiae et therapiae experimentalis.

[31]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[32]  G. Nilsson,et al.  Phenotypic Characterization of the Human Mast‐Cell Line HMC‐1 , 1994, Scandinavian journal of immunology.